Advanced search
Publication Cover
Cancer Biology & Therapy Volume 12, 2011 - Issue 10
Submit an article Journal homepage
805
Views
30
CrossRef citations to date
0
Altmetric
Research Paper

Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer

Svitlana P. Grekova Applied Tumour Virology Programme; Divisions F00 and INSERM Unit 70; German Cancer Research Centre (DKFZ); Heidelberg, GermanyCorrespondence[email protected]
,
Marc Aprahamian Institut de Recherche Contre les Cancers de l'Appareil Digestif; Strasbourg, France
,
Laurent Daeffler Applied Tumour Virology Programme; Divisions F00 and INSERM Unit 70; German Cancer Research Centre (DKFZ); Heidelberg, Germany
,
Barbara Leuchs Applied Tumour Virology Programme; Divisions F00 and INSERM Unit 70; German Cancer Research Centre (DKFZ); Heidelberg, Germany
,
Assia Angelova Applied Tumour Virology Programme; Divisions F00 and INSERM Unit 70; German Cancer Research Centre (DKFZ); Heidelberg, Germany
,
Thomas Giese Institute of Immunology; University Hospital Heidelber; Heidelberg, Germany
,
Angel Galabov The Stephan Angeloff Institute of Microbiology; Bulgarian Academy of Sciences; Sofia, Bulgaria
,
Anette Heller Department of Surgery; University Hospital Heidelberg; Heidelberg, Germany
,
Nathalia A. Giese Department of Surgery; University Hospital Heidelberg; Heidelberg, Germany
,
Jean Rommelaere Applied Tumour Virology Programme; Divisions F00 and INSERM Unit 70; German Cancer Research Centre (DKFZ); Heidelberg, Germany
&
Zahari Raykov Applied Tumour Virology Programme; Divisions F00 and INSERM Unit 70; German Cancer Research Centre (DKFZ); Heidelberg, Germany
 show all
Pages 888-895 | Received 30 May 2011, Accepted 09 Aug 2011, Published online: 15 Nov 2011

References

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M. Cancer Statistics 2009. CA Cancer J Clin 2009; 59:225 - 49; http://dx.doi.org/10.3322/caac.20006; PMID: 19474385
  • Katz MH, Fleming JB, Lee JE, Pisters PW. Current status of adjuvant therapy for pancreatic cancer. Oncologist 2010; 15:1205 - 13; http://dx.doi.org/10.1634/theoncologist.2010-0121; PMID: 21045189
  • Kirn DH, McCormick F. Replicating viruses as selective cancer therapeutics. Mol Med Today 1996; 2:519 - 27; http://dx.doi.org/10.1016/S1357-4310(97)81456-6; PMID: 9015793
  • Cornelis JJ, Haag A, Kornfeld C, Balboni G, Dege A, Neeb B, et al. Autonomous parvovirus vectors In: Cid-Arregui A, Garcia-Garrancá A, eds Viral Vectors: Basic Science and Gene Therapy Natick, MA: Eaton Publishing 2000;97–118.
  • Angelova AL, Aprahamian M, Grekova SP, Hajri A, Leuchs B, Giese NA, et al. Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV. Clin Cancer Res 2009; 15:511 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-08-1088; PMID: 19147756
  • Grekova S, Aprahamian M, Giese N, Schmitt S, Giese T, Falk CS, et al. Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent. Cancer Biol Ther 2011; 10:1280 - 9; http://dx.doi.org/10.4161/cbt.10.12.13455; PMID: 21124075
  • Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163 - 89; http://dx.doi.org/10.1189/jlb.0603252; PMID: 14525967
  • Toporovski R, Morrow MP, Weiner DB. Interferons as potential adjuvants in prophylactic vaccines. Expert Opin Biol Ther 2010; 10:1489 - 500; http://dx.doi.org/10.1517/14712598.2010.521495; PMID: 20836750
  • Miller CH, Maher SG, Young HA. Clinical Use of Interferon-gamma. Ann N Y Acad Sci 2009; 1182:69 - 79; http://dx.doi.org/10.1111/j.1749-6632.2009.05069.x; PMID: 20074276
  • Duluc D, Corvaisier M, Blanchard S, Catala L, Descamps P, Gamelin E. al. Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J Cancer 2009; 125:367 - 73; http://dx.doi.org/10.1002/ijc.24401; PMID: 19378341
  • Windbichler GH, Hausmaninger H, Stummvoll W, Graf AH, Kainz C, Lahodny J, et al. Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial. Br J Cancer 2000; 82:1138 - 44; PMID: 10735496
  • Raitano AB, Scuderi P, Korc M. Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells. Pancreas 1990; 5:267 - 77; http://dx.doi.org/10.1097/00006676-199005000-00005; PMID: 2111548
  • Loos M, Giese NA, Kleeff J, Giese T, Gaida MM, Bergmann F, et al. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer. Cancer Lett 2008; 268:98 - 109; http://dx.doi.org/10.1016/j.canlet.2008.03.056; PMID: 18486325
  • Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011; 331:1612 - 6; http://dx.doi.org/10.1126/science.1198443; PMID: 21436454
  • Hirano S, Etoh T, Okunaga R, Shibata K, Ohta M, Nishizono A, et al. Reovirus inhibits the peritoneal dissemination of pancreatic cancer cells in an immunocompetent animal model. Oncol Rep 2009; 21:1381 - 4; http://dx.doi.org/10.3892/or_00000364; PMID: 19424613
  • Lun XQ, Jang JH, Tang N, Deng H, Head R, Bell JC, et al. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide. Clin Cancer Res 2009; 15:2777 - 88; http://dx.doi.org/10.1158/1078-0432.CCR-08-2342; PMID: 19351762

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.